Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based Vaccine

13 Jul 2010

Abstract excerpt

Group A streptococci (GAS) can cause a wide variety of human infections ranging from asymptomatic colonization to life-threatening invasive diseases. Although antibiotic treatment is very effective, when left untreated, Streptococcus pyogenes infections can lead to poststreptococcal sequelae and severe disease causing significant morbidity and mortality worldwide. To aid the development of a non-M protein-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Neonatal and Maternal Infections
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20624906
DOI: 10.1128/iai.00295-10

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based VaccinePMID 20624906Read ↗

Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococciSemantic proximity Read ↗

Identification of New Candidate Vaccine Antigens Made byStreptococcus pyogenes:Purification and Characterization of 16 Putative Extracellular LipoproteinsSemantic proximity Read ↗

Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Semantic proximity Read ↗

Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae InfectionSemantic proximity Read ↗

The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification markerSemantic proximity Read ↗

Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191Semantic proximity Read ↗

Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine TargetsSemantic proximity Read ↗

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine DevelopmentSemantic proximity Read ↗

Human pathogenic streptococcal proteomics and vaccine development.Semantic proximity Read ↗

Reverse and structural vaccinology approach to design a highly immunogenic multi-epitope subunit vaccine against Streptococcus pneumoniae infection.Semantic proximity Read ↗

Protective activity of Streptococcus pneumoniae Spr1875 protein fragments identified using a phage displayed genomic library.Semantic proximity Read ↗

Group A Streptococcal S Protein Utilizes Red Blood Cells as Immune Camouflage and Is a Critical Determinant for Immune EvasionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.